LIFRAUMENI SYNDROME (CASE REPORT)

The proper clinic observation of LFS (Sarcoma Family Syndrome, OMIM 151623) is considered in the present article, on the example of Russian Blokhin Cancer Reseach Center medical practice. LFS, though being heavily under researched and rarely diagnosed, is one of the most prominent syndromes among hereditary oncological pathologies. LFS - patients often don't receive necessary medical and genetic service in our country while there are accurately defined criteria of diagnostics and a series of definite recommendations on LFS - patients' management and giving medical treatment and consultation to them and their families in the world medical practice. Clinical data of LFS patients proves the necessity of multidisciplinary approaches in the management of sarcoma patients

LiFraumeni syndrome, primary polytumors, TP53 gene, sarcoma

1. Денисов Е.В., Малиновская Е.А, Гарбуков Е.Ю. и соавт. Взаимосвязь соматических мутаций и полиморфизмов генва ТР53 у больных раком молочной железы. Сиб. онколог. журнал. 2007, Пр. 2, с. 39-40.

2. Allgayer H. et al. H. Rehder. Hereditary tumors: From genes to clinical conseqency Wiley-VCH. 2009.

3. Bachinski L.L., Olufemi S.E., Zhou X. et al. Genetic mapping of a third Li-Fraumeni syndrome predisposition locus to human chromosome lq23. Cancer Res. 2005, v. 65, p. 427-431.

4. Birch J.M., Hartley A.L., Trickeretal. Prevalence and diversity of constitutional mutations in the p53 gene among 21 Li-Fraumeni families. Cancer Res. 1994, v. 54, p. 298-1304.

5. Evans D.G.,Wu C.L., Birch J.M. BRCA2:a cause of Li-Fraumenilike syndrome. J. Med. Genet. 2008, v. 45, p. 62-63.

6. Gonzalez K.D., Buzin C.H., Noltner К.A. et al. High frequency of de novo mutations in LiFraumeni syndrome. J. Med. Genet. 2009, v. 46, p. 689-693.

7. Hisada M., Garber J.E., Fung С Y et al. Multiple primary cancers in families with LiFraumeni syndrome. J. Nat. Cancer Inst. 1998, v. 90, p. 606-611.

8. Malkin D., Li F.P., Strong L.C. et al. Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. Science. 1990, v. 250, p. 1233-1238.

9. Li F.P., Fraumeni J.F Rhabdomyosarcoma in children: an epidemiologic study and identification of a familial cancer syndrome. J. Nat. Cancer Inst. 1969, v. 43, p. 1364-1373.

10. Li F.P., Fraumeni J.F., Jr. Prospective study of a family cancer syndrome. JAMA. 1982, v. 247, p. 2692-2694.

11. Li F.P., Fraumeni J.F, Jr. Familial breast cancer, soft-tissue sarcomas, and other neoplasms. Ann. Intern. Med. 1975, v. 83, p. 833-834.

12. Li F.P., Fraumeni J.F, Jr. Softtissue sarcomas, breast cancer, and other neoplasms: a familial syndrome? Ann. Intern. Med. 1969, v. 71, p. 747-752.

13. DataBase TP53 IRCA

14. Li F.P., Fraumeni J.R., Jr. Mulvihill J.J. et al. A cancer family syndrome in twenty four kindreds. Cancer Res. 1988, v. 48, p.5358-5362.

15. Olivier M., Goldgar D.E., Sodha N. et al. Li-Fraumeni and related syndromes: correlation between tumor type, family structure, and TP53 genotype. Cancer Res. 2003, v. 63, p. 6643-6650.

16. Vahteristo P., Tamminen A., Karvinen P. et al. p53, CHK2 and CHK1 genes in Finnish Families with Li-Fraumeni syndrome: further evidence of CHK2 in inherited cancer predisposition. Cancer Res. 2001, v. 61, p. 5718-5722.

17. Varley J.M. Germline TP53 mutations and LiFraumeni syndrome. Hum. Mutat. 2003, v. 21, p. 313-320